Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cellsWarren Fiskus, Michael Pranpat, Maria Balasis, et al.
Leukemia Research|November 7, 2008
Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816VCelalettin Ustun, Christopher L Corless, Natasha Savage, et al.
Blood|March 16, 2006
Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl-expressing human leukemia cellsWarren Fiskus, Michael Pranpat, Purva Bali, et al.
Blood|September 25, 2004
Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cellsFei Guo, Celia Sigua, Purva Bali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3Purva Bali, Prince George, Pamela Cohen, et al.
Cancer Research|November 17, 2005
Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycinFei Guo, Kathy Rocha, Purva Bali, et al.
British Journal of Haematology|August 12, 2009
Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin LymphomaMichael Dickinson, David Ritchie, Daniel J DeAngelo, et al.
Plos One|January 13, 2012
Automated reporter quantification in vivo: high-throughput screening method for reporter-based assays in zebrafishSteven L Walker, Junko Ariga, Jonathan R Mathias, et al.
Autophagy|January 30, 2010
Bortezomib blocks the catabolic process of autophagy via a cathepsin-dependent mechanism, affects endoplasmic reticulum stress and induces caspase-dependent cell death in antiestrogen-sensitive and resistant ER+ breast cancer cellsSudharsan Periyasamy-Thandavan, William H Jackson, Julia S Samaddar, et al.
Blood|June 23, 2010
Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanateYumin Hu, Weiqin Lu, Gang Chen, et al.
Pageof 13